Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D₃ receptor agonists

Abstract

Correction for 'Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D₃ receptor agonists' by Yongkai Cao et al., Med. Chem. Commun., 2018, DOI: 10.1039/c8md00237a.

The authors regret the following errors in their manuscript: in the Abstract, in the sentence beginning ‘Molecular docking demonstrated…’, ‘Phe^7.39’ should be changed to ‘Tyr^7.35’. In section ‘2.4 Molecular basis of selectivity over D2R’, in the sentence beginning ‘Notably, the different orientations…’, ‘Phe365/429’ should be changed to ‘Tyr365/429’. In section ‘3. Conclusion’, in the sentence beginning ‘The different orientations…’, ‘Phe^7.39’ should be changed to ‘Tyr^7.35’.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.